Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Alment praktiserende læge Karen Holbøll ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   4.9% 2.4% 2.5% 2.7% 2.6% 2.8% 11.7% 11.7%   Credit score (0-100)   46 64 61 59 61 58 21 21   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,453 1,705 1,478 1,564 1,523 1,535 0.0 0.0   EBITDA   322 536 464 502 430 413 0.0 0.0   EBIT   125 304 255 353 328 325 0.0 0.0   Pre-tax profit (PTP)   73.3 267.5 237.1 349.5 330.5 339.3 0.0 0.0   Net earnings   55.3 206.5 181.9 266.9 255.2 262.7 0.0 0.0   Pre-tax profit without non-rec. items   73.3 267 237 350 331 339 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   218 150 105 60.5 39.0 13.8 0.0 0.0   Shareholders equity total   409 616 798 1,065 920 932 632 632   Interest-bearing liabilities   1,250 480 451 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,884 1,417 1,451 1,279 1,154 1,184 632 632   Net Debt   159 -352 -584 -880 -674 -972 -632 -632     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,453 1,705 1,478 1,564 1,523 1,535 0.0 0.0   Gross profit growth   6.9% 17.4% -13.3% 5.8% -2.6% 0.8% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,884 1,417 1,451 1,279 1,154 1,184 632 632   Balance sheet change%   10.2% -24.8% 2.4% -11.9% -9.7% 2.6% -46.6% 0.0%   Added value   321.6 536.0 463.7 502.2 477.5 412.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -212 -465 -418 -276 -124 -113 -14 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.6% 17.8% 17.2% 22.5% 21.5% 21.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.0% 18.4% 17.8% 25.9% 27.2% 29.0% 0.0% 0.0%   ROI %   7.9% 22.0% 21.7% 30.6% 33.3% 36.6% 0.0% 0.0%   ROE %   14.5% 40.3% 25.7% 28.7% 25.7% 28.4% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   21.7% 43.5% 55.0% 83.3% 79.7% 78.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   49.3% -65.7% -126.0% -175.3% -156.6% -235.6% 0.0% 0.0%   Gearing %   305.5% 77.9% 56.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 4.2% 3.8% 2.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.9 1.2 1.9 8.6 5.9 6.7 0.0 0.0   Current Ratio   0.9 1.2 1.9 8.6 5.9 6.7 0.0 0.0   Cash and cash equivalent   1,091.6 831.8 1,034.8 880.3 673.8 972.5 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -194.9 196.7 587.8 1,056.6 908.8 975.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   322 536 464 502 477 413 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   322 536 464 502 430 413 0 0   EBIT / employee   125 304 255 353 328 325 0 0   Net earnings / employee   55 206 182 267 255 263 0 0